Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Lifeway Foods Reports 20% Sales Increase in Q3

Tipranks - Wed Sep 3, 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Lifeway Foods ( (LWAY) ) just unveiled an update.

On September 2, 2025, Lifeway Foods announced estimated unaudited net sales of $39.1 million for the first two months of the third quarter, marking a 20% increase from the previous year. This growth highlights the company’s strong market position and increasing consumer demand for its kefir and high-protein cheese products, reinforcing its leadership in the probiotic nutrition sector.

The most recent analyst rating on (LWAY) stock is a Buy with a $33.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.

Spark’s Take on LWAY Stock

According to Spark, TipRanks’ AI Analyst, LWAY is a Outperform.

Lifeway Foods demonstrates strong financial health with robust sales growth and strategic expansions, supported by positive technical indicators. However, high valuation and cash flow challenges slightly temper the overall outlook. The company’s strategic initiatives and positive earnings call sentiment contribute significantly to its favorable score.

To see Spark’s full report on LWAY stock, click here.

More about Lifeway Foods

Lifeway Foods, Inc. is a leading supplier of probiotic, fermented beverages known as kefir in the United States. The company also produces a variety of cheeses and a ProBugs line for kids, with products sold across the U.S., Mexico, Ireland, South Africa, UAE, and France.

Average Trading Volume: 55,782

Technical Sentiment Signal: Buy

Current Market Cap: $464M

For a thorough assessment of LWAY stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.